Bayer's Mirena IUD gets expanded indication
This article was originally published in The Gray Sheet
Bayer Healthcare's Mirena intrauterine device gains expanded FDA approval Oct. 1 to treat heavy menstrual bleeding in women who use intrauterine contraception for pregnancy prevention, making it the first IUD approved for the additional indication. Mirena, a small flexible hormone-releasing device inserted in the uterus, was approved as a contraceptive in 2000
You may also be interested in...
Executive appointments at MyoKardia, Scancell Holdings and Sutro Biopharma
The merger between Mylan and Pfizer’s Upjohn unit finally concluded on 16 November 2020, giving Viatris the go ahead for business. The newly-established company has announced receiving tentative approval for its 10mg pediatric dolutegravir tablets from the FDA under the PEPFAR program.
Johnson & Johnson believes personalization via digital holds the key to smoking cessation success as it launches in the UK its app-supported Nicorette QuickMist SmartTrack product.